Clinical Trial Update: Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery Lesions [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 feasibility trial evaluating a sirolimus-eluting BX Velocity balloon-expandable stent in diabetic patients with native coronary artery lesions has b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• BX Velocity Sirolimus-Eluting Balloon-Expandable Stent (sirolimus-eluting stent)

Snippet

Sponsor: Cordis US Corp. | Conditions: Peripheral Vascular Diseases | Phase 1, Phase 2 | Status: TERMINATED